Literature DB >> 11259168

The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors.

J J Rushton1, S A Ness.   

Abstract

The vertebrate A-Myb, B-Myb, and c-Myb proteins comprise a family of related transcription factors that share a highly conserved DNA binding domain. Although all three proteins are capable of binding the same sites in DNA, they have distinct, but overlapping patterns of expression and are presumed to be regulated independently. Here we show that the transcriptional activity of all three vertebrate Myb proteins can be severely inhibited by coexpression of a dominant-negative allele of p100, a coactivator protein that interacts with Myb DNA binding domains. Thus, the conserved Myb domains mediate interactions with common sites in DNA, as well as common regulators, suggesting that the proteins provide alternative or complementary responses to common upstream signaling pathways. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259168     DOI: 10.1006/bcmd.2001.0405

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  11 in total

1.  B-myb and C-myb play required roles in neuronal apoptosis evoked by nerve growth factor deprivation and DNA damage.

Authors:  David X Liu; Subhas C Biswas; Lloyd A Greene
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

2.  MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb.

Authors:  Jianyi Lu; Min Zhang; Xiao Yang; Tong Cui; Jinpo Dai
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

3.  Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1.

Authors:  Wanli Lei; Fan Liu; Scott A Ness
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

Review 4.  Structure and function of MuvB complexes.

Authors:  Gerd A Müller; Anushweta Asthana; Seth M Rubin
Journal:  Oncogene       Date:  2022-04-26       Impact factor: 8.756

5.  Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.

Authors:  Kathryn J Brayer; Candace A Frerich; Huining Kang; Scott A Ness
Journal:  Cancer Discov       Date:  2015-12-02       Impact factor: 39.397

6.  Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities.

Authors:  John P O'Rourke; Scott A Ness
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

Review 7.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

8.  A supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.

Authors:  Li-Yu D Liu; Li-Yun Chang; Wen-Hung Kuo; Hsiao-Lin Hwa; King-Jen Chang; Fon-Jou Hsieh
Journal:  Comput Math Methods Med       Date:  2014-02-03       Impact factor: 2.238

Review 9.  Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.

Authors:  Olivia L George; Scott A Ness
Journal:  Cancers (Basel)       Date:  2014-10-02       Impact factor: 6.639

10.  Optimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptome.

Authors:  Roger B Brown; Nathaniel J Madrid; Hideaki Suzuki; Scott A Ness
Journal:  PLoS One       Date:  2017-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.